Author:
van Zyl Tavé A.,Modjtahedi Bobeck S.,van Zyl Louis T.
Publisher
Springer International Publishing
Reference59 articles.
1. Bisogni V, Pengo MF, Maiolino G, Rossi GP. The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea. J Thorac Dis [Internet]. 2016;8(2):243–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26904265.
2. Mansukhani MP, Kara T, Caples SM, Somers VK. Chemoreflexes, Sleep Apnea, and Sympathetic Dysregulation. Curr Hypertens Rep [Internet]. 2014;16(9):476. Available from: http://link.springer.com/10.1007/s11906-014-0476-2.
3. Qie R, Zhang D, Liu L, Ren Y, Zhao Y, Liu D, et al. Obstructive sleep apnea and risk of type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of cohort studies. J Diabetes [Internet]. 2020;12(6):455–64. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/1753-0407.13017.
4. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med [Internet]. 2016;165(2):125–33. Available from: http://annals.org/article.aspx?doi=10.7326/M15-2175.
5. Huon L-K, Liu SY-C, Camacho M, Guilleminault C. The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath [Internet]. 2016;20(4):1145–54. Available from: http://link.springer.com/10.1007/s11325-016-1358-4.